Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial

NCT05320926 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

3744

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Heart Disease

Interventions

DRUG: Clopidogrel monotherapy
DRUG: Aspirin monotherapy
DEVICE: zotarolimus-eluting stent (Resolute Onyx ®)

Sponsor

Yonsei University